Freestone Grove Partners »

Kymera Therapeutics shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 157k 83.29

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Axis Cap Hldgs SHS (AXS)
Datadog Cl A Com (DDOG)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
BP Sponsored Adr (BP)
Elastic N V Ord Shs (ESTC)
Pinnacle Finl Partners (PNFP)
Intuitive Surgical Com New (ISRG)
Dynatrace Com New (DT)
Xcel Energy (XEL)
Mondelez Intl Cl A (MDLZ)

View all positions for Freestone Grove Partners

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
BVF
BlackRock
Atlas Venture Life Science Advisors
Wellington Management Company
Siren
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management

View all funds holding Kymera Therapeutics